Psychiatry
Substance Use Disorder
0
Pipeline Programs↗
4
Active Trials↗
1
Companies Involved↗
Substance Use Disorder is an early-stage landscape with 0 programs across 1 company. The most active players are Alicia Bunger.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed3 · 33%
Unknown status2 · 22%
Recruiting2 · 22%
Not yet recruiting1 · 11%
Enrolling by invitation1 · 11%
Clinical Trials
Trial Activity
9 trials
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Recruiting·—·Phase 3·NCT05378399·40 enrolled
Staffing and Supports for Implementing Cross-System Interventions With Peer Mentors
Enrolling by invitation·—·Preclinical·NCT07439783·200 enrolled
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Completed·—·Phase 4·NCT04170738·33 enrolled
Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
Unknown status·—·N/A·NCT05833399·200 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)